BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29476259)

  • 1. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Tajik Z; Bokharaei-Salim F; Ghorbani S; Keyvani H; Esghaei M; Monavari SH; Ataei-Pirkooh A; Garshasbi S; Donyavi T; Fakhim A
    Arch Virol; 2018 Jun; 163(6):1559-1566. PubMed ID: 29476259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients.
    Muche M; Berg T; Rimpler S; Staedtler A; Böhm S; Nickel P; Baid-Agrawal S
    Liver Int; 2019 Feb; 39(2):263-270. PubMed ID: 30171739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection.
    Cassini R; De Mitri MS; Gibellini D; Urbinati L; Bagaglio S; Morsica G; Domenicali M; Verucchi G; Bernardi M
    J Viral Hepat; 2013 Jan; 20(1):42-9. PubMed ID: 23231083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.
    Jiang B; Su R; Ren D; Zheng X; Cao Y; Mi Y; Wang F; Ma P
    Virus Res; 2020 Dec; 290():198117. PubMed ID: 32800804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
    Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
    Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
    Bivigou-Mboumba B; Amougou-Atsama M; Zoa-Assoumou S; M'boyis Kamdem H; Nzengui-Nzengui GF; Ndojyi-Mbiguino A; Njouom R; François-Souquière S
    PLoS One; 2018; 13(1):e0190592. PubMed ID: 29315352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
    PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.